Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-S16 PET/CT in Neurodegenerative Dementia
NCT03620552Phase 1Unknown
- Sponsor
- Oriental Neurosurgery Evidence-Based-Study Team
- Start
- Aug 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 18F-S16 in neurodegenerative dementia, sponsored by Oriental Neurosurgery Evidence-Based-Study Team. Primary endpoint: Semiquantitative assessment of lesions and biodistribution at 1 year. Status: unknown.
02
Drugs
18F-S16
03
Conditions
neurodegenerative dementia
Beyond the preview
Go deeper on NCT03620552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620552.